article thumbnail

HempFusion Closes Acquisition of Apothecanna

Cannabis Law Report

HempFusion’s substantial investment into regulatory compliance will help solidify Apothecanna’s leadership position in the CBD industry. Product efficiencies across topicals line while providing a near term opportunity for expansion into ingestible products supported by HempFusion’s proprietary formulations. FORWARD-LOOKING STATEMENTS.

article thumbnail

Czech Legislature Approves Amendments Re Production & Prescription Of Medical Cannabis & Hemp

Cannabis Law Report

The marketing of extracts such as isolates and tinctures will be permissible. We also spoke with Hana Gabrielová, the CEO of Hemp Point and president of Hemp Cluster , non-profit collective advocating for hemp in the Czech Republic. Export of medical cannabis will now be explicitly legal.

Hemp 51
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HempFusion Announces USD$2,000,000 Strategic Private Placement

Cannabis Law Report

Built on a foundation of regulatory compliance and human safety, HempFusion Wellness offers a diverse product portfolio comprising of over 75 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. HempFusion Wellness Inc. FORWARD-LOOKING STATEMENTS.

article thumbnail

Cannabis and the Environment: Seven Significant Side-Effects April 14, 2022

Cannabis Law Report

Cannabis businesses that are ill-prepared for these regulatory requirements risk facing litigation, enforcement actions, fines or penalties, and negative publicity, while those taking a proactive approach to compliance may find opportunities to mitigate and even monetize those risks.

article thumbnail

HempFusion CBD, In exclusive partnership with Verdant Nature LLC Achieves Major Regulatory Milestone, Ready to Drive Significant Revenue Growth at Retail

Cannabis Law Report

Today, HempFusion and its family of brands are one of the select few CBD companies that stand fully prepared to meet or exceed US & global compliance standards. It’s a common misconception in the industry that when one company achieves this level of compliance, it applies to all other companies. FORWARD-LOOKING STATEMENTS.

Retail 52
article thumbnail

HempFusion Provides Corporate Update, Revenue Guidance

Cannabis Law Report

Substantial investment into regulatory compliance creating a strong base for future FDA regulatory guidelines. The #1 brand in CBD topicals, with 23% market share in the Drug channel [Drug (IRI-SPINScan 52 week ending 7-11-2021)] and 13.8-per-cent pull week ending 5/22/21)]. Exclusivity of the entire supply chain from soil to oil.

Retail 111
article thumbnail

Following the Passage of California’s Assembly Bill 45, HempFusion Plans Retail Expansion

Cannabis Law Report

Utilizing the power of whole-food hemp nutrition, the HempFusion family of brands’ product portfolio comprises 112 SKUs including USDA Organic Certified Tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, probiotic supplements and skin care products, a Doctor/Practitioner line, a White Label division and more.

Retail 52